These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32777220)

  • 41. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes--comparison with conventional methods.
    Al-Marzouqi AH; Jobe B; Dowaidar A; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2007 Jan; 43(2):566-74. PubMed ID: 17010552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations.
    Pallipurath AR; Civati F; Sibik J; Crowley C; Zeitler JA; McArdle P; Erxleben A
    Int J Pharm; 2017 Aug; 528(1-2):312-321. PubMed ID: 28603011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thermodynamic Characteristics of Phenacetin in Solid State and Saturated Solutions in Several Neat and Binary Solvents.
    Przybyłek M; Kowalska A; Tymorek N; Dziaman T; Cysewski P
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solubilization of a novel antitumor drug ribociclib in water and ten different organic solvents at different temperatures.
    Al-Shdefat R; Hailat M; Alshogran OY
    Drug Dev Ind Pharm; 2022 Jan; 48(1):12-20. PubMed ID: 35695255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conformational color polymorphism and control of crystallization of 5-methyl-2-[(4-methyl-2-nitrophenyl)amino]-3-thiophenecarbonitrile.
    He X; Griesser UJ; Stowell JG; Borchardt TB; Byrn SR
    J Pharm Sci; 2001 Mar; 90(3):371-88. PubMed ID: 11170030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solubility measurement, Hansen solubility parameters and solution thermodynamics of gemfibrozil in different pharmaceutically used solvents.
    Kalam MA; Alshehri S; Alshamsan A; Alkholief M; Ali R; Shakeel F
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1258-1264. PubMed ID: 30995878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.
    Hasegawa G; Komasaka T; Bando R; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
    Int J Pharm; 2009 Mar; 369(1-2):12-8. PubMed ID: 19026732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorph screening of an active material.
    Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
    J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
    Tong HH; Shekunov BY; York P; Chow AH
    Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solubility determination of raloxifene hydrochloride in ten pure solvents at various temperatures: Thermodynamics-based analysis and solute-solvent interactions.
    Ahad A; Shakeel F; Alfaifi OA; Raish M; Ahmad A; Al-Jenoobi FI; Al-Mohizea AM
    Int J Pharm; 2018 Jun; 544(1):165-171. PubMed ID: 29679751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple approaches to pharmaceutical polymorphism investigation--a case study.
    Li H; Kiang YH; Jona J
    Eur J Pharm Sci; 2009 Dec; 38(5):426-32. PubMed ID: 19748574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of nicergoline polymorphs crystallized in several organic solvents.
    Malaj L; Censi R; Capsoni D; Pellegrino L; Bini M; Ferrari S; Gobetto R; Massarotti V; Di Martino P
    J Pharm Sci; 2011 Jul; 100(7):2610-22. PubMed ID: 21254066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphism in metoclopramide hydrochloride and metoclopramide.
    Mitchell AG
    J Pharm Pharmacol; 1985 Sep; 37(9):601-4. PubMed ID: 2867177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supercritical antisolvent precipitation of nimesulide: preliminary experiments.
    Moneghini M; Perissutti B; Vecchione F; Kikic I; Alessi P; Cortesi A; Princivalle F
    Curr Drug Deliv; 2007 Jul; 4(3):241-8. PubMed ID: 17627498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorph control of sulfathiazole in supercritical CO2.
    Kordikowski A; Shekunov T; York P
    Pharm Res; 2001 May; 18(5):682-8. PubMed ID: 11465426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
    Sun CC
    Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on the crystal forms of pefloxacin: preparation, characterization, and dissolution profile.
    Yadav MR; Shaikh AR; Ganesan V; Giridhar R; Chadha R
    J Pharm Sci; 2008 Jul; 97(7):2637-48. PubMed ID: 17854073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization.
    Tong HH; Wu HB; Zheng Y; Xi J; Chow AH; Chan CK
    Int J Pharm; 2008 May; 355(1-2):195-202. PubMed ID: 18207676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.